P2.16. Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Noemí Reguart Aransay
Meta Tag
Speaker Noemí Reguart Aransay
Topic SCLC & Neuroendocrine Tumors: Trials in Progress
Keywords
PEERS phase 2 trial
pembrolizumab
lenvatinib
chemotherapy
extensive-stage small cell lung cancer
efficacy
safety
immune checkpoint inhibitors
tyrosine kinase inhibitor
preclinical and clinical studies
Powered By